公司简介

Agilis Biotherapeutics is advancing innovative DNA therapeutics designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous system

主要成员

Michael Boice、Frank Borchetta、Frederico Lourenco

产品/服务

• 科技服务

Agilis Engineered DNA Therapeutics。

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2014-01	未披露	$8M

关联公司